CAR-T Cells: Future Perspectives

被引：51

作者：

Charrot, Sarah ^{[1
,2
]}

Hallam, Simon ^{[1
,2
]}

机构：

[1] St Bartholomews Hosp, London, England

[2] QMUL, Barts Canc Inst, London, England

来源：

HEMASPHERE | 2019年 / 3卷 / 02期

关键词：

CHIMERIC-ANTIGEN-RECEPTOR; ANTITUMOR-ACTIVITY; MESSENGER-RNA; B-CELL; EXPRESSION; IMMUNOTHERAPY; CD8(+); COSTIMULATION; LYMPHOCYTES; THERAPIES;

D O I：

10.1097/HS9.0000000000000188

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页数：9

共 57 条

[1] Strategies to Address Chimeric Antigen Receptor Tonic Signaling [J].

Ajina, Adam ;

Maher, John .

MOLECULAR CANCER THERAPEUTICS, 2018, 17 (09) :1795-1815

[2] CAR T-cells for T-cell malignancies: challenges in distinguishing between therapeutic, normal, and neoplastic T-cells [J].

Alcantara, Marion ;

Tesio, Melania ;

June, Carl H. ;

Houot, Roch .

LEUKEMIA, 2018, 32 (11) :2307-2315

[3] Mesothelin-Specific Chimeric Antigen Receptor mRNA-Engineered T Cells Induce Antitumor Activity in Solid Malignancies [J].

Beatty, Gregory L. ;

Haas, Andrew R. ;

Maus, Marcela V. ;

Torigian, Drew A. ;

Soulen, Michael C. ;

Plesa, Gabriela ;

Chew, Anne ;

Zhao, Yangbing ;

Levine, Bruce L. ;

Albelda, Steven M. ;

Kalos, Michael ;

June, Carl H. .

CANCER IMMUNOLOGY RESEARCH, 2014, 2 (02) :112-120

[4] Targeting the adenosine 2A receptor enhances chimeric antigen receptor T cell efficacy [J].

Beavis, Paul A. ;

Henderson, Melissa A. ;

Giuffrida, Lauren ;

Mills, Jane K. ;

Sek, Kevin ;

Cross, Ryan S. ;

Davenport, Alexander J. ;

John, Liza B. ;

Mardiana, Sherly ;

Slaney, Clare Y. ;

Johnstone, Ricky W. ;

Trapani, Joseph A. ;

Stagg, John ;

Loi, Sherene ;

Kats, Lev ;

Gyorki, David ;

Kershaw, Michael H. ;

Darcy, Phillip K. .

JOURNAL OF CLINICAL INVESTIGATION, 2017, 127 (03) :929-941

[5] T Cells Genetically Modified to Express an Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor Cause Remissions of Poor-Prognosis Relapsed Multiple Myeloma [J].

Brudno, Jennifer N. ;

Maric, Irina ;

Hartman, Steven D. ;

Rose, Jeremy J. ;

Wang, Michael ;

Lam, Norris ;

Stetler-Stevenson, Maryalice ;

Salem, Dalia ;

Yuan, Constance ;

Pavletic, Steven ;

Kanakry, Jennifer A. ;

Ali, Syed Abbas ;

Mikkilineni, Lekha ;

Feldman, Steven A. ;

Stroncek, David F. ;

Hansen, Brenna G. ;

Lawrence, Judith ;

Patel, Rashmika ;

Hakim, Frances ;

Gress, Ronald E. ;

Kochenderfer, James N. .

JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (22) :2267-+

[6] Combining a CD20 Chimeric Antigen Receptor and an Inducible Caspase 9 Suicide Switch to Improve the Efficacy and Safety of T Cell Adoptive Immunotherapy for Lymphoma [J].

Budde, Lihua E. ;

Berger, Carolina ;

Lin, Yukang ;

Wang, Jinjuan ;

Lin, Xubin ;

Frayo, Shani E. ;

Brouns, Shaunda A. ;

Spencer, David M. ;

Till, Brian G. ;

Jensen, Michael C. ;

Riddell, Stanley R. ;

Press, Oliver W. .

PLOS ONE, 2013, 8 (12)

[7] Chimeric Antigen Receptor-T Cell Therapy Practical Considerations for Implementation in Europe [J].

Buechner, Jochen ;

Kersten, Marie Jose ;

Fuchs, Miriam ;

Salmon, Florence ;

Jager, Ulrich .

HEMASPHERE, 2018, 2 (01)

[8] Potent anti-leukemia activities of humanized CD19-targeted Chimeric antigen receptor T (CAR-T) cells in patients with relapsed/refractory acute lymphoblastic leukemia [J].

Cao, Jiang ;

Wang, Gang ;

Cheng, Hai ;

Wei, Chen ;

Qi, Kunming ;

Sang, Wei ;

Li Zhenyu ;

Shi, Ming ;

Li, Huizhong ;

Qiao, Jianlin ;

Pan, Bin ;

Zhao, Jing ;

Wu, Qingyun ;

Zeng, Lingyu ;

Niu, Mingshan ;

Jing, Guangjun ;

Zheng, Junnian ;

Xu, Kailin .

AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (07) :851-858

[9] Heparanase promotes tumor infiltration and antitumor activity of CAR-redirected T lymphocytes [J].

Caruana, Ignazio ;

Savoldo, Barbara ;

Hoyos, Valentina ;

Weber, Gerrit ;

Liu, Hao ;

Kim, Eugene S. ;

Ittmann, Michael M. ;

Marchetti, Dario ;

Dotti, Gianpietro .

NATURE MEDICINE, 2015, 21 (05) :524-U158

[10]

Caruso HG, 2016, J IMMUNOTHER, V39, P205, DOI 10.1097/CJI.0000000000000126

← 1 2 3 4 5 6 →